med-challenge-gradient-tcm9-576.jpg

Medical Devices and Technology

Medtech companies face significant challenges, old and new. BCG uses deep industry knowledge, proprietary tools, and customized solutions to turn these challenges into opportunities.

Even before the COVID-19 pandemic, companies in every sector of the medical devices and technology industry grappled with the quickening pace of innovation, slowing product pipelines, changing sales models, increased competition—and newer challenges stemming from the increasing presence of digital in every aspect of the business.

But the flip side of challenge is opportunity, and the opportunities in this high-growth, high-margin industry are many. They include using advancements in medical technology to improve health care delivery and embracing digital to improve operations. BCG’s medical technology consulting experts help clients assess their priorities and strengths and then move decisively to optimize operations, marketing and sales, R&D innovation, and other parts of the business.

medical-devices-technology-insights-challenge-tcm9-2929.jpg

Umstrukturierung Ihres Geschäftsmodells im medizintechnischen Bereich in sechs Schritten.

Mehr Erkenntnisse

Die MedTech Quality Remediation Toolbox beinhaltet ein umfassendes Paket diagnostischer Tools, die von BCG konzipiert wurden, um Unternehmen bei der Qualitätsoptimierung zu unterstützen.

Unsere Lösungen
med-impact-teaser-01-tcm9-2931.jpg

Ein Medizintechnikunternehmen erstellt eine integrierte digitale Plattform für therapieübergreifende Behandlungen.

Mehr über unseren Impact

BCG Tools and Solutions for the Medtech Industry

BCG’s medical technology consulting practice blends its expertise in medtech strategies with a set of proprietary tools, including comparative benchmarks, databases, and other knowledge assets. Some highlights:

Meet BCG’s Medical Device Consulting Experts

Our Latest Thinking About the Medtech Industry

As-Vaccines-Roll-Out-Testing-Still-Matters-rectangle.jpg

As Vaccines Roll Out, Testing Still Matters

Multiple scenarios for the US and four EU countries point to a continued need for COVID-19 testing through 2024, with demand peaking in the seasonally affected first quarters of 2021 and 2022.

 

SUBSCRIBE